Abstract
The advent of transcatheter procedures for treatment of valvular heart disease has accelerated the pace of research in the diagnosis and treatment of heart valve disease. Rapid accumulation of novel knowledge in the field necessitates timely revisions of clinical guidelines. This paper comments on some important and novel issues addressed in the recently published American College of Cardiology/American Heart Association (ACC/AHA) guidelines.
| Original language | English |
|---|---|
| Pages (from-to) | 786-789 |
| Number of pages | 4 |
| Journal | Wiener Klinische Wochenschrift |
| Volume | 133 |
| Issue number | 15-16 |
| DOIs | |
| Publication status | Published - Aug 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- American Heart Association
- Cardiology
- Heart Valve Diseases/surgery
- Humans
- Transcatheter Aortic Valve Replacement
- United States
Fingerprint
Dive into the research topics of 'New strategies in the management of valvular heart disease: A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver